PD-1 and PD-L1 Inhibitors
Middle East · 2 shared keywords
Updated
Reviewed by Chandani Patel
Middle East Cancer Vaccines Market Industry Trends and Forecast to 2034: Segmented by (Type, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$612.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $317.1 Mn | — | — |
| 2025 (base) | $354.5 Mn | +$37.4 Mn | — |
| 2026 (forecast) | $396.3 Mn | +$41.8 Mn | +11.8% |
| 2027 (forecast) | $443.1 Mn | +$46.8 Mn | +25% |
| 2028 (forecast) | $495.4 Mn | +$52.3 Mn | +39.7% |
| 2029 (forecast) | $553.8 Mn | +$58.5 Mn | +56.2% |
| 2030 (forecast) | $619.2 Mn | +$65.3 Mn | +74.7% |
| 2031 (forecast) | $692.2 Mn | +$73.1 Mn | +95.3% |
| 2032 (forecast) | $773.9 Mn | +$81.7 Mn | +118.3% |
| 2033 (forecast) | $865.2 Mn | +$91.3 Mn | +144.1% |
| 2034 (forecast) | $967.3 Mn | +$102.1 Mn | +172.9% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $354.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $967.3 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 11.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type, indication and end user (see all) |
| Key players | Moderna, Merck & Co., Inc., BioNTech, Dendreon Pharmaceuticals LLC, Gritstone bio (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Cancer vaccines train the immune system to recognise and attack cancer, including personalised mRNA vaccines and preventive vaccines.
Key segments of the cancer Vaccines market include type (Personalized Neoantigen Vaccines, Preventive Vaccines and Dendritic Cell Vaccines) and indication (Melanoma, Lung Cancer and Prostate Cancer).
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the cancer Vaccines market. Faster approvals and new combinations are improving survival.
Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the cancer Vaccines market.
High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the cancer Vaccines market, especially in low- and middle-income countries.
The cancer Vaccines market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medicines are approved by SFDA (Saudi Arabia)[1] and EDE (UAE)[2]. How care is paid for in some of these countries: free public care and CHI-regulated insurance (Saudi Arabia)[3] and mandatory health insurance (UAE)[4].
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Emirates Drug Establishment. Checked 14 Nov 2026.
[3] Council of Health Insurance. Checked 14 Nov 2026.
[4] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for cancer Vaccines. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Middle East.
What doctors and scientists are doing in Cancer Vaccines right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Middle East · 2 shared keywords
Middle East · 2 shared keywords
Middle East · 2 shared keywords
Middle East · 2 shared keywords
Middle East · 1 shared keyword
Middle East
Digital Health · Middle East
Healthcare Services · Middle East
Healthcare Services · Middle East
Healthcare Services · Middle East
Medical Devices · Middle East
Healthcare Services · Middle East